US Drug Firms Seek Inversion Deals to Evade Taxes – New York Times


New York Times
US Drug Firms Seek Inversion Deals to Evade Taxes
New York Times
“There’s a lot of cost savings when you’re dealing with acquisitions among pharmaceutical companies,” said Juliane Keppler, managing director of the global tax and regulatory team within Nasdaq OMX Corporate Solutions. “It’s less expensive to merge
Pharmaceutical firm Shire to fall into hands of US rival AbbVie after it This is Money
Shire Pharmaceutical ready to accept AbbVie’s advancesProactive Investors UK
No Rival Bidder Emerging to Battle AbbVie for ShireWall Street Journal
Quartz -Chicago Business Journal -Athlete Newswire
all 386 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd